Clinical Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

About the Cover

Cover Figure


The Cover

The specific FTI, R115777, reduces hypoxia in human glioma xenograft xenografts. U87 tumor-bearing mice were treated with vehicle or with R115777 then injected with pentafluorinated 2-nitroimidazole (EF5) to detect hypoxia that appears in red. While U87 xenografts presented large regions of hypoxia in absence of treatment (upper panel), the treated tumors showed little evidence of hypoxia (lower panel). For details, see C. Delmas et al., in this issue.



[Table of Contents]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.